2014
Asthma medication use during pregnancy, wheeze and estimated exposure to ambient nitrogen dioxide
Gent JF, Kezik JM, Hill ME, McKay LA, Holford TR, Leaderer BP, Bracken MB. Asthma medication use during pregnancy, wheeze and estimated exposure to ambient nitrogen dioxide. European Respiratory Journal 2014, 45: 538-540. PMID: 25537555, PMCID: PMC4331059, DOI: 10.1183/09031936.00161514.Peer-Reviewed Original ResearchConceptsAsthma medication useMedication usePregnant womenRisk of wheezePoor pulmonary functionAdverse health outcomesPregnant asthmaticsAsthma exacerbationsAsthma medicationsPerinatal complicationsPulmonary functionFetal growthHealth outcomesPregnancyNO2 exposureWheezeAsthmaMedicationsWomenAmbient nitrogen dioxideMothersMinimal effectExposureAsthmaticsExacerbation
1986
A Study of Respiratory Effects from Exposure to 2 ppm Formaldehyde in Healthy Subjects
Schachter E, Witek T, Tosun T, Leaderer B, Beck G. A Study of Respiratory Effects from Exposure to 2 ppm Formaldehyde in Healthy Subjects. Archives Of Environmental & Occupational Health 1986, 41: 229-239. PMID: 3767432, DOI: 10.1080/00039896.1986.9938338.Peer-Reviewed Original ResearchConceptsHealthy subjectsUpper airwaySeparate daysMaximal flow-volume curvesLower airway symptomsFlow-volume curvesAirway responsesAirway symptomsPulmonary functionRespiratory symptomsSignificant bronchoconstrictionLung functionSymptom diaryAirway resistanceIrritative phenomenaModerate exercisePhysiologic alterationsRespiratory effectsSubjective complaintsBaseline responsivenessFA exposureHealthy individualsIrritative propertiesRespiratory systemSuch exposure